Article Information
- Received March 18, 2017
- Revision received July 17, 2017
- Accepted July 17, 2017
- Published online August 7, 2017.
Author Information
- Sabyasachi Dash1,2,3,
- Muthukumar Balasubramaniam1,2,4,
- Tanu Rana2,4,
- Arthur Godino6,
- Emily G. Peck6,
- Jeffery Shawn Goodwin2,4,
- Fernando Villalta5,
- Erin S. Calipari6,7,
- Eric J. Nestler6,
- Chandravanu Dash1,2,4 and
- Jui Pandhare1,2,3,5
- 1Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN 37208
- 2Center for Molecular and Behavioral Neuroscience, Meharry Medical College, Nashville, TN 37208
- 3School of Graduate Studies and Research, Meharry Medical College, Nashville, TN 37208
- 4Department of Biochemistry and Cancer Biology, Meharry Medical College, Nashville, TN 37208
- 5Department of Microbiology and Immunology, Meharry Medical College, Nashville, TN 37208
- 6Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232
- 7Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
- Correspondence should be addressed to either of the following: Jui Pandhare, Ph.D., Old Hospital Building-CAHDR, Room 5023, 1005 Dr. DB Todd Jr Boulevard, Nashville, TN 37208, E-mail: jpandhare{at}mmc.edu; or Chandravanu Dash, Ph.D., Old Hospital Building-CAHDR, Room 5027, 1005 Dr. DB Todd Jr Boulevard, Nashville, TN 37208, E-mail: cdash{at}mmc.edu.
Author contributions
Author contributions: S.D., M.B., F.V., E.S.C., E.J.N., C.D., and J.P. designed research; S.D., M.B., T.R., A.G., E.G.P., J.S.G., E.S.C., and J.P. performed research; S.D., M.B., J.S.G., F.V., E.S.C., E.J.N., C.D., and J.P. analyzed data; C.D. and J.P. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was partly supported by National Institutes of Health (NIH) Grants DA037779 (to J.P.), DA024558, DA30896, DA033892, DA021471, and AI22960 (to C.D.), DA008227 (to E.J.N.), and DA042111 (to E.S.C.). We work was also supported by the RCMI Grant G12MD007586, the Vanderbilt CTSA Grant UL1RR024975, the Meharry Translational Research Center (MeTRC) CTSA grant (U54 RR026140 from NCRR/NIH, the U54 Grant MD007593 from NIMHD/NIH, and the Tennessee Center for AIDS Research (P30 AI110527).
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
DA037779; DA024558; DA30896; DA033892; DA021471; DA008227 and DA042111
Other Version
- You are viewing the most recent version of this article.
- previous version (August 07, 2017).
Online Impact